CYTOKINETICS, INCORPORATED : CYTK Stock Price | … Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. CYTK | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for CYTOKINETICS INC (CYTK), including profile, stock chart, recent news and events, analyst opinions, and research reports. analyst opinions, stock price movement, earnings data, and industry comparisons. Available only to Fidelity customers. Compustat ® Company Report S&P Global. CYTK - Cytokinetics News - Barchart.com Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
CYTK - Cytokinetics News - Barchart.com
But as Cytokinetics has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably 31 Mar 2020 Cytokinetics Incorporated [NASDAQ: CYTK] stock went on an upward path that rose over 8.85% on Monday, amounting to a one-week price 8 Nov 2019 Incorporated (Nasdaq: CYTK) today announced that it has agreed to of Cytokinetics' common stock exceeds 130% of the conversion price Cytokinetics Announces Pricing Of Public Offering Of Convertible Senior Notes. 6 months ago. Cytokinetics Says Expects To Sell An Aggregate Of $100 Mln CYTK / Cytokinetics, Inc. - Institutional Ownership and Shareholders File Date, Form, Investor, Opt, Avg Share Price, Shares, Shares Changed (%), Value
PRESS RELEASES | Cytokinetics, Inc.
Learn about CYTK with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on CYTK. CYTK: Cytokinetics Inc - Stock Price, Quote and News - CNBC Get Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news and financial information from CNBC.
CYTK | Cytokinetics Inc. Stock Price & News - WSJ
CYTK Stock Price | Cytokinetics Inc. Stock Quote (U.S ... CYTK | Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Cytokinetics, Incorporated (CYTK) Stock Price, Quote ... Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing.
Real-time trade and investing ideas on Cytokinetics Inc. CYTK from the largest community of traders and investors.
Cytokinetics (CYTK) delivered earnings and revenue surprises of -23.81% and -27.51%, respectively, for the quarter ended December 2019. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Cytokinetics, Incorporated (CYTK) Stock Forum & Discussion ... Find the latest Cytokinetics, Incorporated (CYTK) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
The latest closing stock price for Guardant Health as of April 06, 2020 is 66.99. The all-time share price. The average Guardant Health stock price for the last 52 weeks is 78.35. Cytokineticsorporated (CYTK), United States, $0.711B, 0.00 . #Cytokinetics Announces Pricing of #PublicOffering of Convertible Senior Notes $CYTK Bearish stock to watch: Cytokinetics, Inc. (NASDAQ: CYTK) CYTK Stock Price | Cytokinetics Inc. Stock Quote (U.S ... CYTK | Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.